Teriparatide + Teriparatide + placebo

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
25
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Safety

Conditions

Drug Safety

Trial Timeline

Jul 1, 2011 โ†’ Aug 1, 2013

About Teriparatide + Teriparatide + placebo

Teriparatide + Teriparatide + placebo is a phase 1 stage product being developed by Entera Bio for Drug Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT02202603. Target conditions include Drug Safety.

Hype Score Breakdown

Clinical
10
Activity
5
Company
2
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02202603Phase 1Completed